Abstract:Tumorigenesis is always concomitant with microenvironmental alterations. The tumor microenvironment is a heterogeneous and complex milieu, which exerts a variety of stresses on tumor cells for proliferation, survival, or death. Recently, accumulated evidence revealed that metabolic and oxidative stresses both play significant roles in tumor development and progression that converge on a common autophagic pathway. Tumor cells display increased metabolic autonomy, and the hallmark is the exploitation of aerobic glycolysis (termed Warburg effect), which increased glucose consumption and decreased oxidative phosphorylation to support growth and proliferation. This characteristic renders cancer cells more aggressive; they devour tremendous amounts of nutrients from microenvironment to result in an ever-growing appetite for new tumor vessel formation and the release of more "waste," including key determinants of cell fate like lactate and reactive oxygen species (ROS). The intracellular ROS level of cancer cells can also be modulated by a variety of stimuli in the tumor microenvironment, such as pro-growth and pro-inflammatory factors. The intracellular redox state serves as a double-edged sword in tumor development and progression: ROS overproduction results in cytotoxic effects and might lead to apoptotic cell death, whereas certain level of ROS can act as a second-messenger for regulation of such cellular processes as cell survival, proliferation, and metastasis. The molecular mechanisms for cancer cell responses to metabolic and oxidative stresses are complex and are likely to involve multiple molecules or signaling pathways. In addition, the expression and modification of these proteins after metabolic or oxidative stress challenge are diverse in different cancer cells and endow them with different functions. Therefore, MS-based high-throughput platforms, such as proteomics, are indispensable in the global analysis of cancer cell responses to metabolic and oxidative stress. Herein, we highlight recent advances in the understanding of the metabolic and oxidative stresses associated with tumor progression with proteomics-based systems biology approaches.

High-throughput screening of cellular redox sensors using modern redox proteomics approaches

Thiol-based redox proteomics in cancer research.

Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities.

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy

Targeting ROS in cancer: rationale and strategies

Targeting Metabolic-Redox Circuits for Cancer Therapy

Detection of ROS Induced Proteomic Signatures by Mass Spectrometry

Redox Signaling at the Crossroads of Human Health and Disease

Redox Regulation in Tumor Cell Epithelial–mesenchymal Transition: Molecular Basis and Therapeutic Strategy

Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA

Redox regulation and its emerging roles in cancer treatment

Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis

Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy

Redox control of the survival of healthy and diseased cells.

Redox Sensing by Proteins: Oxidative Modifications on Cysteines and the Consequent Events

[A Review of the Redox Regulation of Tumor Metabolism].

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Mitochondrial Redox Signaling And Tumor Progression